Pilot Grants in Drug Discovery and Development; Request for Applications
Deadline: February 25, 2013 – 8:30 AM
The UAB Center for Emerging Drug Discovery, the UAB CCTS, and the Alabama Drug Discovery Alliance plan to fund up to 3 pilot grants for $50,000 per year for up to 2 years, with funding of Year 2 dependent on progress made in Year 1.
Funds can be utilized for any aspect of drug discovery and development for any human disease, including—but not limited to—target validation, assay development for highthroughput screening, molecular modeling and medicinal chemistry efforts, or proof of concept studies in animals. Only small molecule‐directed efforts are eligible for funding at this time.
The ADDA is a joint effort between the UAB School of Medicine and Southern Research Institute. If needed, access to Southern Research’s expertise and resources is therefore facilitated (e.g., high‐throughput screening, medicinal chemistry, cancer cellular models (NCI60), angiogenesis models, xenograft models, PK, bioanalysis and safety studies). For all funded projects, a multi‐disciplinary team will be assembled, consisting of members with relevant expertise, including cell biology, pharmacology, medicinal chemistry, HTS assay development as well as clinical knowledge. This team will help create a compound progression pathway and guide the project through the drug discovery and development pipeline.
For more information and instructions on how to apply, click here:ADDA RFA Spring 2013.pdf